In this episode of the Immunity Group Australia Podcast, leading pediatric allergist Dr. Jose Costa shares how early allergen introduction, personalized care, and innovative immunotherapy protocols are transforming the way we treat allergies.

Dr. Costa opens up about his journey into allergy medicine and explains the science behind oral immunotherapy (OIT)—a treatment approach giving hope to families dealing with severe food allergies. He also discusses promising research using omalizumab (Xolair) to enhance OIT outcomes and why the UK is a critical next step in expanding access to care.

Learn how airborne allergen immunotherapy could help reduce food allergies, asthma, and eczema, and why outdated advice on allergen avoidance may be causing more harm than good. Dr. Costa's vision challenges the status quo and offers a new path forward for clinicians, parents, and allergy sufferers alike.